Evolent Health (EVH) Operating Income (2015 - 2026)

Evolent Health has reported Operating Income for 12 years, with the latest figure at -$9.6 million in Q2 2026.

• On a quarterly basis, Operating Income fell 716.48% year-over-year to -$9.6 million in Q2 2026; TTM through Jun 2026 was -$427.5 million, a 1035.26% decrease from a year earlier, with the FY2025 full-year figure at -$410.1 million, down 913.06% from the prior year.
• Operating Income was -$9.6 million for Q2 2026 at Evolent Health, up from -$10.6 million in the prior quarter.
• The five-year high for Operating Income was $13.0 million in Q3 2022, with the low at -$408.2 million in Q4 2025.
• Average Operating Income over 5 years is -$29.9 million, with a median of -$10.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Operating Income soared 296.79% in 2022, then slumped 2095.26% in 2025.
• Over 5 years, Operating Income stood at -$1.9 million in 2022, then sank by 1036.85% to -$21.3 million in 2023, then rose by 12.9% to -$18.6 million in 2024, then plunged by 2095.26% to -$408.2 million in 2025, then surged by 97.66% to -$9.6 million in 2026.
• The last three Operating Income figures came in at -$9.6 million (Q2 2026), -$10.6 million (Q1 2026), and -$408.2 million (Q4 2025), per Business Quant data.